Bladder cancer patients in the U.S. have seen a number of recent FDA approvals of different immunotherapies to treat the disease.
In this webinar for patients and caregivers, Dr. Arjun Balar of the NYU Langone Medical Center in New York, NY, discusses the latest research and developments in bladder cancer immunotherapy. This webinar was recorded Friday, May 19, 2017.
The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, Genentech, Regeneron, and Advaxis.
